BioGaia AB (LTS:0GTN) EBIT per Share : kr4.65 (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB EBIT per Share?

BioGaia AB's EBIT per Share for the three months ended in Dec. 2023 was kr0.86. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr4.65.

During the past 12 months, the average EBIT per Share Growth Rate of BioGaia AB was 31.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was 16.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 5.60% per year. During the past 10 years, the average EBIT per Share Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for BioGaia AB's EBIT per Share or its related term are showing as below:

LTS:0GTN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -58.9 Med: 16.7 Max: 192.6
Current: 16.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of BioGaia AB was 192.60% per year. The lowest was -58.90% per year. And the median was 16.70% per year.

LTS:0GTN's 3-Year EBIT Growth Rate is ranked better than
63.76% of 850 companies
in the Drug Manufacturers industry
Industry Median: 7.95 vs LTS:0GTN: 16.70

BioGaia AB's EBIT for the three months ended in Dec. 2023 was kr86 Mil.

BioGaia AB EBIT per Share Historical Data

The historical data trend for BioGaia AB's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB EBIT per Share Chart

BioGaia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

2.78

2.56

2.51

4.49

4.65

BioGaia AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															1.51	1.49	1.01	1.29	0.86

BioGaia AB EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

BioGaia AB's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	469.643	/	100.982
=	4.65

BioGaia AB's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	86.406	/	100.982
=	0.86

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.65

BioGaia AB (LTS:0GTN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

BioGaia AB EBIT per Share Related Terms

Thank you for viewing the detailed overview of BioGaia AB's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB (LTS:0GTN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

BIOGY:USA BGLAF:USA BIOG B:Sweden BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB (LTS:0GTN) Headlines

No Headlines